Extended Data Fig. 2: ORR by CTFI, prior LOT, prior Top1i chemotherapy exposure, and brain metastasis at study entry among patients in the 1.8 mg kg−1 cohort. | Nature Medicine

Extended Data Fig. 2: ORR by CTFI, prior LOT, prior Top1i chemotherapy exposure, and brain metastasis at study entry among patients in the 1.8 mg kg−1 cohort.

From: SEZ6-targeting antibody−drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial

Extended Data Fig. 2: ORR by CTFI, prior LOT, prior Top1i chemotherapy exposure, and brain metastasis at study entry among patients in the 1.8 mg kg−1 cohort.The alternative text for this image may have been generated using AI.

CTFI, chemotherapy free interval; CTx, chemotherapy; LOT, line of therapy; Mets, metastasis; ORR, objective response rate; Top1i, topoisomerase 1 inhibitor.

Back to article page